biogen news | Biogen to Realign Resources for Alzheimer's Disease Fran

Keyword	CPC	PCC	Volume	Score	Length of keyword
biogen news	1.85	1	2940	71	11
biogen	0.28	0.8	3665	4	6
news	0.44	0.7	2375	33	4

Keyword	CPC	PCC	Volume	Score
biogen news	1.32	0.1	7962	61
biogen news today	1.61	0.5	3943	8
biogen news layoffs	1.69	0.3	1257	27
biogen news 2023	0.27	0.9	7916	40
biogen news releases	1.6	0.7	2441	27
biogen newsroom	1.54	0.5	87	86
biogen news 2021	0.07	0.8	1764	8
biogen news 2022	1.6	0.9	559	97
biogen news today negative update	1.15	0.1	4703	1
biogen news alzheimer	1.95	0.9	9140	63
biogen news headlines	1.26	0.7	633	98
biogen news june 7 2021	0.3	0.3	2388	14
biogen stock news	0.97	0.4	633	54
biogen stock news today	1.16	0.3	1903	2
biogen current news	0.42	0.6	7309	51
biogen pharma share price news	0.19	0.7	3310	82
biogen aducanumab news	0.09	0.6	7964	87
biogen inc news	0.57	0.9	2691	75

Search Results related to biogen news on Search Engine

Biogen to Realign Resources for Alzheimer's Disease Franchise
biogen.com

https://investors.biogen.com/news-releases/news-release-details/biogen-realign-resources-alzheimers-disease-franchise

WEBJanuary 31, 2024 • News Release. CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced plans to reprioritize its resources in Alzheimer’s disease (AD), a strategic therapeutic area expected to drive near and long-term growth.

DA: 51 PA: 82 MOZ Rank: 33

News | Biogen
biogen.com

https://investors.biogen.com/news/news-releases

WEBMay 7, 2018 · Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression. January 29, 2023. News Release.

DA: 23 PA: 35 MOZ Rank: 97

Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, …
yahoo.com

https://finance.yahoo.com/news/biogen-qalsody-tofersen-first-therapy-120000872.html

WEBCAMBRIDGE, Mass., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted...

DA: 66 PA: 42 MOZ Rank: 8

FDA Approves Biogen’s Drug for Rare Form of ALS - The New York Times
nytimes.com

https://www.nytimes.com/2023/04/25/business/biogen-fda-als-drug.html

WEBBy Rebecca Robbins. April 25, 2023. The Food and Drug Administration on Tuesday authorized the first drug for a rare genetic form of the neurological disorder A.L.S., despite uncertainty about the...

DA: 96 PA: 70 MOZ Rank: 85

Biogen Inc. (BIIB) Latest Stock News & Headlines - Yahoo Finance
yahoo.com

https://finance.yahoo.com/quote/BIIB/news/

WEBNews. Press Releases. SEC Filings. What's in Store for Biogen (BIIB) This Earnings Season? Biogen's (BIIB) sales in the first quarter are likely to have been hurt by lower sales of its...

DA: 63 PA: 7 MOZ Rank: 13

Biogen to Present New Data at the Clinical Trials on Alzheimer’s
biogen.com

https://investors.biogen.com/news-releases/news-release-details/biogen-present-new-data-clinical-trials-alzheimers-disease-ctad

WEBOctober 19, 2023 • News Release. Late-breaking Phase 1b data assesses the clinical outcomes of reducing tau in patients with early-stage Alzheimer’s disease. Additional late-breaking presentations from the CLARITY AD study explore predictive biomarkers and novel subcutaneous administration of LEQEMBI ® (lecanemab-irmb)

DA: 25 PA: 16 MOZ Rank: 89

Biogen CEO bets on Alzheimer's drug, pipeline to return to growth
reuters.com

https://www.reuters.com/business/healthcare-pharmaceuticals/biogen-earnings-beat-estimates-boost-muscle-disorder-drug-2023-02-15/

WEBFeb 15 (Reuters) - Biogen Inc (BIIB.O) Chief Executive Officer Christopher Viehbacher said on Wednesday he is banking on high-profile launches of Alzheimer's disease treatment Leqembi and...

DA: 19 PA: 93 MOZ Rank: 23

Biogen’s Alzheimer’s drug approved by FDA, first new therapy in …
cnbc.com

https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html

WEBJun 7, 2021 · Biogen shares surge 38% after FDA approves Alzheimer's drug, the first new therapy for the disease in nearly two decades. Published Mon, Jun 7 202111:03 AM EDT Updated Mon, Jun 7 20214:13 PM...

DA: 90 PA: 23 MOZ Rank: 7

U.S. approval of Biogen Alzheimer's drug sends shares soaring, …
reuters.com

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-set-rule-controversial-biogen-alzheimers-drug-2021-06-07/

WEBJun 8, 2021 · June 7 (Reuters) - U.S. regulators on Monday approved Biogen Inc's (BIIB.O) aducanumab as the first treatment to attack a likely cause of Alzheimer's disease despite controversy over whether the...

DA: 20 PA: 20 MOZ Rank: 77

Alzheimer’s Drug Slows Cognitive Decline in Key Study
nytimes.com

https://www.nytimes.com/2022/09/27/business/alzheimers-drug-biogen-lecanemab.html

WEBSep 27, 2022 · The pharmaceutical companies Biogen and Eisai said on Tuesday that a drug they are developing for Alzheimer’s disease had slowed the rate of cognitive decline in a large late-stage clinical trial.

DA: 45 PA: 50 MOZ Rank: 31